Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

TOMI Environmental Solutions, Inc. Expands Presence in the United Kingdom With New Distribution Agreement


Posted on: 19 Dec 17

BEVERLY HILLS, Calif., Dec. 19, 2017 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc. (“TOMI”) (OTCQX:TOMZ), a global decontamination company that specializes in disinfection/decontamination sales and services, including SteraMist™, a hydrogen peroxide-based mist/fog registered with the U.S. Environmental Protection Agency (“EPA”) for use as a hospital-healthcare disinfectant and used worldwide as a decontaminate has entered into a sales and distribution agreement with Westbury Decontamination, a United Kingdom-based service and distribution company and part of the Westbury Group of companies.

As part of the agreement, Westbury will distribute the TOMI™ line of products and were granted rights in both geographic territories and multiple industries. This agreement has resulted in purchases to date and will also lead to future purchases of SteraMist™ equipment as Westbury prepares to address the growing need for this technology in its market.

Dr. Shane shared that TOMI recognized Westbury as a valuable addition to its growing list of international distributors and is confident that the inclusion of  SteraMist™ products will increase Westbury’s revenue opportunities with a competitive edge to grow their business.

Westbury Decontamination Division Director, Phillip Godden, stated, “Westbury Decontamination is thrilled to be the UK’s official distributor of the TOMI™ line of products and services. Our existing customer base is already engaged and committed to using this new and leading technology for rapid, reliable biological decontaminations through many sectors.”

About TOMI Environmental Solutions, Inc.
TOMI Environmental Solutions, Inc. (OTCQX:TOMZ) is a global decontamination and infection prevention company, providing environmental solutions for indoor surface disinfection through manufacturing, sales and licensing of its premier Binary Ionization Technology® (BIT™) platform, which was invented under a defense grant in association with the Defense Advanced Research Projects Agency (DARPA) of the U.S. Department of Defense. BIT™ uses a low percentage Hydrogen Peroxide as its only active ingredient to produce a hydroxyl radical (OH ion), represented by the TOMI™ SteraMist™ brand of products, which produces a germ-killing aerosol that works like a visual non-caustic gas.

TOMI’s products are designed to service a broad spectrum of commercial structures including but not limited to hospitals and medical facilities, cruise ships, office buildings, hotel and motel rooms, schools, restaurants, meat and produce processing facilities (when not in operation), military barracks, police and fire departments, and athletic facilities. TOMI’s products and services have also been used in single-family homes and multi-unit residences. TOMI also develops training programs and application protocols for its clients and is a member in good standing of The American Biological Safety Association, The American Association of Tissue Banks, Association for Professionals in Infection Control and Epidemiology, Society for Healthcare Epidemiology of America and The Restoration Industry Association.

For additional information, please visit http://www.tomimist.com/ or contact us at info@tomimist.com.

About Westbury

Since the 1960’s the name Westbury has been synonymous with utilizing air filter engineering to create safe, clean and productive working environments.

Today, this expertise in engineering, coupled with our continuous quest for leading technology is fundamental to our success in providing world class products & services to specification and on time.

Our clients include small businesses, blue-chip private companies, as well as the government sectors, we are a preferred supplier for many of the UK’s leading facilities management companies.

The company’s strong reputation has been earned by providing well designed, high quality solutions, together with a superior level of customer service, both pre and post order.

The Westbury Decontamination division is dedicated to providing rapid biological decontamination to a broad customer base.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995

Certain written and oral statements made by us may constitute “forward-looking statements” as defined in the Private Securities Litigation Reform Act of 1995 (the “Reform Act”). Forward-looking statements are identified by such words and phrases as “we expect,” “expected to,” “estimates,” “estimated,” “current outlook,” “we look forward to,” “would equate to,” “projects,” “projections,” “projected to be,” “anticipates,” “anticipated,” “we believe,” “could be,” and other similar phrases. All statements addressing operating performance, events, or developments that we expect or anticipate will occur in the future, including statements relating to revenue growth, earnings, earnings-per-share growth, or similar projections, are forward-looking statements within the meaning of the Reform Act. They are forward-looking, and they should be evaluated in light of important risk factors that could cause our actual results to differ materially from our anticipated results. The information provided in this document is based upon the facts and circumstances known at this time. We undertake no obligation to update these forward-looking statements after the date of this release

MEDIA RELATIONS CONTACT

Juliana deRosa
Executive Administrator
jderosa@tomimist.com

GlobeNewswire
globenewswire.com

Last updated on: 20/12/2017

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.